What makes the Israel's Life Science Industry a strong hub? The cumulative number of active life science companies in Israel over the last decade: The number of active Israel life science companies has been increasing over time. [...]
Why is RGL Research taking part in the Digital Technology Revolution? The rising of digital technologies in the Healthcare sector, A paradox: In the past decade, digital technologies have been transforming all worldwide industries [...]
New Handheld Sensor Identifies Allergens In Food A new handheld sensor is created due to the fact that food allergies have become very common in children in recent years. Food allergies may cause people to [...]
AI Tech Uses Facial Analysis To Detect Rare Genetic Disorders AI Tech is a company that created a technology to help doctors determine rare genetic disorders in children. [...]
RGL Research - Winner of Les Pépites Tech Startup contest RGL Research • March 2019 W e are very proud to announce that RGL Research has been registered as the most [...]
FDA clarifies pathway for devices used in regenerative medicine RGL Research • Feb 2019 The regenerative medicine field includes tissue engineering, which involves developing biological substitutes. It can restore or [...]
Vestibulum cursus in ligula lacinia lobortis. Morbi at velit at velit auctor efficitur ut ac justo. Donec quam est, suscipit vel ligula ut, aliquet maximus libero. Pellentesque finibus tellus vitae dolor lacinia eleifend.
AB Science: Development of masitinib, a novel tyrosine kinase inhibitor and immunotherapeutic, for the treatment of peripheral T-cell lymphoma
Nulla sit amet nunc massa. Praesent sed est pellentesque, varius tellus non, efficitur nisi. Sed sit amet purus in odio varius tincidunt. Mauris ut ante lobortis, elementum orci efficitur, bibendum leo.
Vestibulum cursus in ligula lacinia lobortis. Morbi at velit at velit auctor efficitur ut ac justo. Phasellus porttitor, elit vitae scelerisque vestibulum, nunc libero bibendum massa.